pyrazines has been researched along with ADPKD in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, X; He, J; Huang, H; Jenny Lu, HA; Jia, Y; Jin, W; Li, M; Li, X; Meng, J; Qiu, Z; Shao, G; Wang, L; Wang, S; Xu, Y; Yang, B; Zhang, S; Zhou, H | 1 |
| Fan, S; Li, A; Li, Y; Liang, C; Meng, J; Shen, X; Wu, D; Wu, G; Xiao, Q; Xu, Y; Zhang, L; Zhang, X | 1 |
2 other study(ies) available for pyrazines and ADPKD
| Article | Year |
|---|---|
Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model.
Topics: Aminopyridines; Animals; Benzamides; Cell Culture Techniques; Cell Proliferation; Disease Models, Animal; Dogs; Epithelial Cells; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hydroxamic Acids; Mice; Mice, Inbred C57BL; Polycystic Kidney, Autosomal Dominant; Pyrazines; Signal Transduction; Sulfonamides | 2021 |
Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.
Topics: Animals; beta Catenin; Disease Models, Animal; Female; Heterocyclic Compounds, 3-Ring; Humans; Injections, Intraperitoneal; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Polycystic Kidney, Autosomal Dominant; Pyrazines; Pyridines; Random Allocation; Survival Analysis; Treatment Outcome; TRPP Cation Channels; Wnt Signaling Pathway | 2018 |